NCT04652544View on ClinicalTrials.gov

Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions
Spinal Cord InjuriesVitamin D Deficiency
Interventions
DRUG

Cholecalciferol (Vitamin D3)

Vi-De 3® Monthly Dose from Dr. Wild \& Co. AG (Muttenz, Switzerland) is a commercially available vitamin D3 supplement.

OTHER

Placebo

A placebo will be produced, consisting of the same ethanol solution as Vi-De 3® Monthly Dose, but without cholecalciferol.

Trial Locations (1)

6207

Swiss Paraplegic Centre, Nottwil

All Listed Sponsors
lead

Swiss Paraplegic Research, Nottwil

NETWORK